Portfoliotracker

Retension Pharmaceuticals, Inc.

RTSN · NASDAQCM · Healthcare Biotechnology

11,46 $
▼ −0,81 (−6,60 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 14:14
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score– Market cap102 mil. $ P/E– Forward P/E-5,1 P/S– P/B-0,7 EV/EBITDA– Dividend yield– FCF yield– EPS-2,61 $ Net margin0,0 % Return on equity– Beta– Debt / equity–
52-week range 9,66 to 18,64
3-month average volume0,2 M

We do not have financial statements yet

We do not have statements for this company yet. You can see the price and its history above.

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.

Employees
12
Country
United States
Data since
9. 10. 2026

Explore further

Similar companies TRXBETRALTGOCOAGKARD

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account